FDA Panel Ends Peptide Review Backing Six of Seven, with Emideltide Rejected in a 6 to 7 Vote
Likely AI
The meeting is over, and the final tally is not what the first day suggested. By the close of Friday afternoon, the FDA's Pharmacy Compounding Advisory Committee had recommended adding six of the seven...
The Verdict
ClassificationLikely AI
ConfidenceHigh confidence
Analyzedtext, image
ImageAI Generated
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/ab018d65-c798-4a6f-aa33-4b958a5da797)